Vienna scientists have developed an innovative oral peptide therapy that offers a safe, non-opioid solution for chronic abdominal pain, providing effective relief with minimal side effects and no addiction risk.
(c) Cottonbro Studio/Pexels CC0
(c) Cottonbro Studio/Pexels CC0

Nuevo tratamiento innovador para el dolor abdominal crónico

EUREKALERT

Científicos de Viena han desarrollado una innovadora terapia con péptidos orales que ofrece una solución segura y no opioide para el dolor abdominal crónico, proporcionando un alivio eficaz con efectos secundarios mínimos y sin riesgo de adicción.

Read Full Story

Entradas relacionadas

Los Más Leídos

An Essex couple trialled a HeatHub—a mini data-centre in their garden shed with over 500 computers—to heat their home while moving from gas boiler to solar setup. Their monthly bills dropped from about £375 to just £40-£60, blending innovation with home comfort.
Centro de datos en un cobertizo reduce la factura de calefacción a £40
The European Commission has launched a plan to slash major journey times on Europe’s high-speed rail network by about 50%, with examples like Berlin–Copenhagen in 4 h instead of 7 by 2030 and Sofia–Athens in 6 h instead of nearly 14 by 2035, while unlocking investment and harmonising systems for faster, greener travel.
Viajar en Europa en la mitad del tiempo: velocidad y sostenibilidad van de la mano
France’s Parliament approved a major reform: any sexual act without explicit, informed, revocable consent will now be criminalized. The law defines consent as “free, specific, prior and revocable,” ensuring silence or no reaction is not considered agreement.
Francia incorpora el consentimiento en la ley sobre violación tras el caso Pelicot
Ireland is extending its “Basic Income for the Arts” pilot into a permanent scheme: 2,000 creatives were paid €325/week during the trial to stabilize income and support artistic practice. The plan seeks to nurture talent, reduce financial stress, and strengthen the arts sector.
Irlanda convierte el ingreso básico para artistas en programa permanente